Status:
RECRUITING
Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Lead Sponsor:
National Cancer Centre, Singapore
Collaborating Sponsors:
National Medical Research Council (NMRC), Singapore
Duke-NUS Graduate Medical School
Conditions:
Nasopharyngeal Cancer
Prostate Cancer
Eligibility:
All Genders
21-99 years
Brief Summary
Patients with cancers that are sensitive to radiotherapy treatment and/or patients who have experienced severe acute/ late side effects to radiotherapy will be recruited to the study. Blood and/or mat...
Eligibility Criteria
Inclusion
- Patients with severe side effects from radiotherapy
- Patients with a type of cancer that is associated with sensitivity to radiotherapy
Exclusion
- Age of patient must be between 21 (inclusive) and 99 (exclusive)
Key Trial Info
Start Date :
September 30 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04340024
Start Date
September 30 2015
End Date
December 31 2026
Last Update
June 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Center Singapore
Singapore, Singapore, 169690